Report cover image

In Vitro Diagnostics Business Outlook,Volume 4, Issue 2 - Focus on Infectious Disease Testing

Publisher Kalorama Information
Published Apr 01, 2025
Length 44 Pages
SKU # KLI20138694

Description

The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.

As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.

In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
  • Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
  • Comprehensive Market View: Coverage of test categories and company profiles.
  • M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
  • Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
  • News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.

Table of Contents

44 Pages
MARKET ANALYSIS: INFECTIOUS DISEASE TESTING
OVERVIEW OF INFECTIOUS DISEASE TESTING
MARKET OUTLOOK
Table 1: Global Infectious Disease Testing Market Revenue, by Segment, 2024-2029 ($ million) [Lab-based Immunoassays, Lab-based Molecular, Point-of-Care Tests]
Figure 1: Global Infectious Disease Testing Market, by Segment, 2019-2029 ($ million) [Lab-based Immunoassays, Lab-based Molecular, Point-of-Care Tests]
Figure 2: Global Infectious Disease Testing Market, Change in Market Performance by Segment, 2023-2024 [Blood Bank Screening, COVID-19, HAIs/Sepsis, Hepatitis, HIV, Respiratory (excl. COVID), Others]
Figure 3: Global Infectious Disease Testing Market, by Analyte Target, Distribution of Sales, 2024 [Blood Bank Screening, COVID-19, HAIs/Sepsis, Hepatitis, HIV, Respiratory (excl. COVID), Others]
REGIONAL MARKET
Table 2: Infectious Disease Testing, Distribution by Global Region, 2024 [North America, Europe, Asia Pacific, RoW]
COMPANY BRIEFS
Roche
Abbott
Danaher
Other Participants
EXECUTIVE NEWS BRIEFING
BRIEFINGS
Dxcover Limited Raises New Capital
Cubit Diagnostics Awarded NIH Funding
CARB-X Funds AstraDx’s Neonatal Sepsis Rapid Test
Freenome Raises Additional $254 Million
Renovaro Secures $15 Million in New Capital
Ataraxis AI Secures $20.4 Million in Funding
MSInsight Nabs €1.6 Million Seed Funding
C2N Diagnostics Receives $10 Million Investment
FINANCIAL HIGHLIGHTS: GUARDANT HEALTH, ROCHE
GUARDANT REPORTS STRONG DEMAND – INCREASING REVENUES +31% OVER PREVIOUS YEAR
Figure 4: Guardant Health Test Volume, by Segment and Total, Quarterly Q1 2023 through Q4 2024 [Biopharmaceutical Customers, Clinical Customers]
Table 3: Guardant Health, by Group Business Revenue, FY 2023 vs FY 2024 ($ million) [Clinical Precision Oncology Testing, Development Services and Other]
Figure 5: Guardant Health, by Group Business, FY 2023 vs FY 2024 ($ million) [Clinical Precision Oncology Testing, Development Services and Other]
Figure 6: Guardant Health Revenue Performance, by Geographic Region, FY 2023 vs FY 2024 ($ million) [United States, International]
ROCHE DIAGNOSTIC SALES GROW 4% CER IN 2024 – SUPPORTED BY DEMAND FOR IMMUNODIAGNOSTICS, PATHOLOGY, AND MOLECULAR SOLUTIONS
Table 4: Roche, by Group Business, 2024 (CHF MN) [Diagnostic Division, Pharmaceutical Division]
Figure 7: Roche Diagnostics, 2024 Product Sales Breakdown, 2024 (CHF MN) [Core Lab, Molecular, Pathology Lab, Point-of-Care]
Figure 8: Roche Diagnostic, Segment Distribution, 2024 (%) [Core Lab, Molecular, Pathology Lab, Point-of-Care]
Table 5: Roche Diagnostics Division Sales, by Region, 2024 (CHF MN)
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS, AND PARTNERSHIP DEALS
MERGERS AND ACQUISITIONS
Table 6: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals, Dec. 2024-March 2025
PARTNERSHIPS AND COLLABORATIONS
INDUSTRY WATCH
INDUSTRY WATCH COVID-19/FLU UPDATE
REGION WATCH
BRAZIL
Figure 9: Brazil Short-Term GDP Growth and Inflation Change, 2022-2024, 2025-2026 Projected (%)
Figure 10: Brazil General Government Gross Debt as a Percent of GDP, 2000-2020 and 2025 projected (%)
Figure 11: Brazil IVD Market Distribution of Sales, by IVD Segment, 2024 (%)
BROAD-BASED COMPANY ANNOUNCEMENTS
ANNOUNCEMENTS
AliveDx Nabs CE Mark for Expanded Autoimmune Menu
Beckman Coulter Received FDA Breakthrough Device Designation
Beckton Dickinson to Spin Off Bioscience and Diagnostic Business
GRAIL Provides Galleri Multi-Cancer Early Detection Test Through Quest
Molecular Instruments RNA-ISH Enables Breakthrough LDT
Roche Snags FDA Clearance for Preeclampsia Test
CytoChip Receives FDA Clearance and CLIA Waiver
Cicero Diagnostics Unveiled Endometriosis Detection LDT
bioMérieux Secures FDA Clearance for BIOFIRE FILMARRAY GI Panel
Beckman Coulter Gains Clearance for its DxC 500i

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us